DECISION Deliverable Reports
The goal of this policy is to provide a framework of public engagement in research in DECISION to align this project with the Responsible Research and Innovation (RRI) framework.
This document is an analysis of the current codes of good conduct published by each member of the DECISION project: Here, we discuss what is included in the DECISION partners’ code of conduct, any references to national or international guidelines, how easily accessible the relevant information is from the home page and the general usefulness of the document for the members of the institutions themselves and the public.
This checklist is meant as an all-operative document the purpose of which is to facilitate the identification, compliance, and verification of the key aspects related to research involving potential participants, the uses of human biological samples, and/or personal data. It allows identifying ethical issues, but also methodological aspects, legal requirements and the societal impact of the research projects.
D7.4 First patient and layman event (PDF | 1,22 MB)
‘Therapies for acute decompensation of cirrhosis and ACLF, research needs and outlook.’ Under this title, on June 9, 2021, an event was organized dedicated to patients focused on DECISION, MICROB-PREDICT, and A-TANGO, medical research project.
D7.5 Second patient and layman event (PDF | 1,8 MB)
The COMBAT-trial: A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome.’ Under this title, on March, 6th, an event was organized dedicated to patients